[1] 吕志强,于佳,张蔚,等.侵袭性真菌感染的预后因素分析
[J].中国医师杂志,2014,16,(7):925-929.

[2] 韩玉坤,曲芬,周华.医院感染有效监控与合理治疗的实践与认识
[J].中华医院感染学杂志,2005,15,(3):318-321.

[3] Wójtowicz A,Tissot F,Lamoth F,et al.Polymorphisms in tumor necrosis factor-α increase susceptibility to intra-abdominal Candida infection in high-risk surgical ICU patients
[J].Crit Care Med,2014,42(4):e304-308.

[4] Qidwai T,Khan F.Tumour necrosis factor gene polymorphism and disease prevalence
[J].Scand J Immunol,2011,74(6):522-547.

[5] Ibrahim AS,Gebremariam T,Lin L,et al.The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis
[J].Molecular Microbiology,2010,77(3):587-604.

[6] Chen M,Zhang C,Pan WH,et al.Pulmonary fungus ball caused by Penicilliumcapsulatum in a patient with type 2 diabetes:acasereport
[J].BMC Infectious Diseases,2013,13(10):496.

[7] Cornely OA,Bhme A,Buchheidt D,et al.Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies.Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology
[J].Haematologica,2009,94(1):113-122.

[8] Portugal RD,Garnica M,Nucci M.Index to predict invasive mold infection in high-risk neutropenic patients based on the area over the neutrophil curve
[J].J Clin Oncol,2009,27(23):3849-3854.

[9] Garcia-Vidal C,Upton A,Kirby KA,et al.Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients:biological risk factors for infection according to time after transplantation
[J].Clin Infect Dis,2008,47(8):1041-1150.

[10] Hung Chen-Yiu,Kao Kuo-Chin,Wang Po-Nan,et al.Invasive fungal infection among hematopoietic stem cell transplantation patients with mechanical ventilation in the intensive care unit
[J].BMC Infect Dis 2012,12(2):44.

[11] Kim HA,Jeon JY,An JM,et al.C-reactive protein is a more sensitive and specific marker for diagnosing bacterial infections in systemic lupus erythematosus compared to S100A8/A9 and procalcitonin
[J].J Rheumatol,2012,39(4):728-734.

[12] de Oliveira RB,Atobe JH,Souza SA,et al.Epidemiology of invasive fungal infections in patients with acquired immunodeficiency syndrome at a reference hospital for infectious diseases in Brazil
[J].Mycopathologia,2014,178(1-2):71-78.

[13] Ostrosky-Zeichner L.Clinical prediction rules for invasive candidiasis in the ICU:Ready for prime
[J]?Crit Care,2011,15(5):189.

[14] Dupont H,Bourichon A,Paugam-Burtz C,et al.Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis
[J]?Crit Care Med,2003,31(3):752-757.

[15] Hermsen ED,Zapapas MK,Maiefski M,et al.Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients:a matched case-control study
[J].Crit Care,2011,15(4):R198.

[16] Hu Bo,Du Zhaohui,Kang Yan,et al.Catheter-related Candida bloodstream infection in intensive care unit patients:a subgroup analysis of the China-SCAN study
[J].BMC Infectious Diseases,2014,14(1):594.

[17] Limper AH,Knox KS,Sarosi GA,et a1.An official American thoracic society statement:treatment of fungal infections in adult pulmonary and critical care patients
[J].Am J Respir And Crit Care Med,2011,183(1):96-128.

[18] Luzzati R,Cavinato S,Giangreco M,et al.Peripheral and total parenteral nutrition as the strongest risk factors for nosocomial candidemia in elderly patients:a matched case-control study
[J].Mycoses,2013,56(6):664-671.

[19] Samonis G,Galanakis E,Ntaoukakis M,et al.Effects of carbapenems and their combination with amikacin on murine gut colonisation by Candida albicans
[J].Mycoses,2013,56(2):105-109.